Adenosine inhibits matrix metalloproteinase-9 secretion by neutrophils -: Implication of A2a receptor and cAMP/PKA/Ca2+ pathway

被引:59
作者
Ernens, Isabelle
Rouy, Didier
Velot, Emilie
Devaux, Yvan
Wagner, Daniel R.
机构
[1] Ctr Hosp Luxembourg, Div Cardiol, L-1210 Luxembourg, Luxembourg
[2] CRP Sante, Cardiovasc Res Lab, Luxembourg, Luxembourg
关键词
adenosine; neutrophils; myocardial remodeling; protein kinase A; matrix metalloproteinase-9;
D O I
10.1161/01.RES.0000241428.82502.d4
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Matrix metalloproteinases (MMPs), and in particular MMP-9 secreted by neutrophils, are capable of degrading the matrix components of the heart and are thought to be the driving force behind myocardial matrix remodeling after infarction. Adenosine, a naturally produced nucleoside, has been shown to have cardioprotective effects and to inhibit secretion of various cytokines. The aim of our study was to determine the effect of adenosine on the secretion of MMP-9 by neutrophils. Neutrophils were isolated from healthy volunteers through Ficoll and Dextran sedimentation. Neutrophils were activated by N-formylmethionyl-leucyl-phenylalanine (fMLP) in the presence or absence of adenosine or adenosine analogs. Zymography and enzyme linked immunosorbent assay were used to measure MMP-9 secretion. Adenosine (1 mu mol/L) decreased the fMLP-induced MMP-9 secretion by 30 +/- 2% (n = 8, P < 0.001). The effect was dose-dependent and was not specific to fMLP because adenosine also inhibited MMP-9 secretion by LPS- or H2O2-stimulated neutrophils. The effect of adenosine was mimicked by the adenosine A2a receptor agonist CGS21680 and was inhibited by both the A2a antagonist SCH5826 and A2a RNA silencing. The A3 agonist IB-MECA moderately decreased fMLP-induced MMP-9 secretion. Agonists and antagonists of the other types of adenosine receptors had no significant effect. Adenosine increased intracellular cAMP concentration and accelerated the return to baseline of the intracytoplasmic calcium peak. The inhibition of MMP-9 secretion by adenosine, as well as the calcium effect, was prevented by the protein kinase A inhibitor H-89. In conclusion, we show here that adenosine inhibits MMP-9 secretion by neutrophils. Our results suggest that this effect implies the A2a receptor and is mediated through the cAMP/PKA/Ca2+ pathway. Therefore, adenosine may represent a new approach to prevent matrix degradation and remodeling after myocardial injury.
引用
收藏
页码:590 / 597
页数:8
相关论文
共 35 条
  • [11] Activation of A(3) adenosine receptors on human eosinophils elevates intracellular calcium
    Kohno, Y
    Ji, XD
    Mawhorter, SD
    Koshiba, M
    Jacobson, KA
    [J]. BLOOD, 1996, 88 (09) : 3569 - 3574
  • [12] QUANTITATIVE-ANALYSIS OF THE CYTOSOLIC FREE CALCIUM DEPENDENCY OF EXOCYTOSIS FROM 3 SUBCELLULAR COMPARTMENTS IN INTACT HUMAN-NEUTROPHILS
    LEW, PD
    MONOD, A
    WALDVOGEL, FA
    DEWALD, B
    BAGGIOLINI, M
    POZZAN, T
    [J]. JOURNAL OF CELL BIOLOGY, 1986, 102 (06) : 2197 - 2204
  • [13] Predictors of late development of heart failure in stable survivors of myocardial infarction - The CARE study
    Lewis, EF
    Moye, LA
    Rouleau, JL
    Sacks, FM
    Arnold, JMO
    Warnica, JW
    Flaker, GC
    Braunwald, E
    Pfeffer, MA
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (08) : 1446 - 1453
  • [14] Adenosine as an adjunct to thrombolytic therapy for acute myocardial infarction - Results of a multicenter, randomized, placebo-controlled trial: The Acute Myocardial Infarction STudy of ADenosine (AMISTAD) Trial
    Mahaffey, KW
    Puma, JA
    Barbagelata, NA
    DiCarli, MF
    Leesar, MA
    Browne, KF
    Eisenberg, PR
    Bolli, R
    Casas, AC
    Molina-Viamonte, V
    Orlandi, C
    Blevins, R
    Gibbons, RJ
    Califf, RM
    Granger, CB
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 1999, 34 (06) : 1711 - 1720
  • [15] MCGARRITY ST, 1989, J IMMUNOL, V142, P1986
  • [16] Myocardial infarct expansion and matrix metalloproteinase inhibition
    Mukherjee, R
    Brinsa, TA
    Dowdy, KB
    Scott, AA
    Baskin, JM
    Deschamps, AM
    Lowry, AS
    Escobar, P
    Lucas, DG
    Yarbrough, WM
    Zile, MR
    Spinale, FG
    [J]. CIRCULATION, 2003, 107 (04) : 618 - 625
  • [17] Human A2A adenosine receptors:: High-affinity agonist binding to receptor-G protein complexes containing Gβ4
    Murphree, LJ
    Marshall, MA
    Rieger, JM
    MacDonald, TL
    Linden, J
    [J]. MOLECULAR PHARMACOLOGY, 2002, 61 (02) : 455 - 462
  • [18] OLAH ME, 1994, MOL PHARMACOL, V45, P978
  • [19] Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851
  • [20] Evolution of matrix metalloprotease and tissue inhibitor expression during heart failure progression in the infarcted rat
    Peterson, JT
    Li, H
    Dillon, L
    Bryant, JW
    [J]. CARDIOVASCULAR RESEARCH, 2000, 46 (02) : 307 - 315